Evidence map›Paper›PMID 34716335›Full record

ArticleNPJ Parkinson's disease2021

White matter and nigral alterations in multiple system atrophy-parkinsonian type.

Takashi Ogawa, Taku Hatano, Koji Kamagata, Christina Andica, Haruka Takeshige-Amano, Wataru Uchida, Daiki Kamiyama, Yasushi Shimo, Genko Oyama, Atsushi Umemura and 5 more

Open access · goldAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Neuroimaging in multiple system atrophy: clinical implications and novel developments.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Takashi OgawaDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-7335-0672
Taku HatanoDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan. thatano@juntendo.ac.jp.ORCID http://orcid.org/0000-0002-6808-0444
Koji KamagataDepartment of Radiology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Christina AndicaDepartment of Radiology, Faculty of Medicine, Juntendo University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9339-6950
Haruka Takeshige-AmanoDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Wataru UchidaDepartment of Radiology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Daiki KamiyamaDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Yasushi ShimoDepartment of Neurology, Juntendo University Nerima Hospital, Tokyo, Japan.
Genko OyamaDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Atsushi UmemuraDepartment of Neurosurgery, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Hirokazu IwamuroDepartment of Neurosurgery, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Masanobu ItoDepartment of Psychiatry, Faculty of Medicine Juntendo University, Tokyo, Japan.
Masaaki HoriDepartment of Radiology, Toho University Omori Medical Center, Tokyo, Japan.
Shigeki AokiDepartment of Radiology, Faculty of Medicine, Juntendo University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-8491-0698
Nobutaka HattoriDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan. nhattori@juntendo.ac.jp.
Juntendo University · JPJuntendo University Nerima Hospital · JPToho University · JP

Funding

Japan Agency for Medical Research and Development (AMED) 19dm0207070Japan Agency for Medical Research and Development (AMED) 19dm0307024Japan Agency for Medical Research and Development (AMED) 19dm030710Japan Agency for Medical Research and Development (AMED) 19ek0109358
6 · The paper itself

Abstract

Multiple system atrophy (MSA) is classified into two main types: parkinsonian and cerebellar ataxia with oligodendrogliopathy. We examined microstructural alterations in the white matter and the substantia nigra pars compacta (SNc) of patients with MSA of parkinsonian type (MSA-P) using multishell diffusion magnetic resonance imaging (dMRI) and myelin sensitive imaging techniques. Age- and sex-matched patients with MSA-P (n = 21, n = 10 first and second cohorts, respectively), Parkinson's disease patients (n = 19, 17), and healthy controls (n = 20, 24) were enrolled. Magnetization transfer saturation imaging (MT-sat) and dMRI were obtained using 3-T MRI. Measurements obtained from diffusion tensor imaging (DTI), free-water elimination DTI, neurite orientation dispersion and density imaging (NODDI), and MT-sat were compared between groups. Tract-based spatial statistics analysis revealed differences in diffuse white matter alterations in the free-water fractional volume, myelin volume fraction, and intracellular volume fraction between the patients with MSA-P and healthy controls, whereas free-water and MT-sat differences were limited to the middle cerebellar peduncle in comparison with those with Parkinson's disease. Region-of-interest analysis of white matter and SNc revealed significant differences in the middle and inferior cerebellar peduncle, pontine crossing tract, corticospinal tract, and SNc between the MSA-P and healthy controls and/or Parkinson's disease patients. Our results shed light on alterations to brain microstructure in MSA.

Identifiers

PMID34716335
PMCPMC8556415
OpenAlexW3208812445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.